Building Functional Living 3D Tissues using a Unique Microfluidics Based Bioprinting Technology

BIOMEDICAL RESEARCH CENTRE SEMINAR SERIES Presents

Dr. Sam Wadsworth, PhD

Aspect Biosystems Ltd.

Vancouver, Canada

“Building Functional Living 3D Tissues using a Unique Microfluidics Based Bioprinting Technology”

 “Sam Wadsworth, Ph.D., Chief Scientific Officer & Co-Founder Aspect Biosystems.  Sam is a world leader in the field of human airway tissue engineering and has published many peer-reviewed papers on related research. He completed his Ph.D. in respiratory cell biology in the UK before relocating to Vancouver in 2007 to work as a Post-Doctoral Research Fellow at the UBC Centre for Heart + Lung Innovation at St. Paul’s Hospital. Since 2011 Sam has spearheaded inter-disciplinary, cross-Canada research projects to build living 3-Dimensional human airway tissues. In 2013 Sam co-founded Aspect Biosystems with Konrad Walus, Simon Beyer and Tamer Mohamed. Aspect is a tissue engineering company with proprietary 3D-bioprinting technology capable of fabricating a variety of physiologically-relevant human tissues. Sam will be discussing Aspect’s unique technology, and will describe how this has the potential to revolutionise the fields of pharmaceutical drug development, disease research, personalised and regenerative medicine by providing living human tissues on demand.”

Friday, March 24th 2017

4:00 pm to 5:00 pm

The Biomedical Research Centre

2222 Health Sciences Mall

Hosted by Dr. Fabio Rossi

fabio@brc.ubc.ca